Open Access Statement

 
Academic Transparency & Global Reach

Open Access Statement

Innovation Biology Research (IBR) is a peer-reviewed, international scholarly journal that operates under a Gold Open Access model. We are committed to the principle that making biological research freely available to the public supports a greater global exchange of knowledge. By removing barriers to access, IBR facilitates the rapid dissemination of scientific discoveries, fostering innovation in life sciences, biotechnology, and medicine.

Copyright and Licensing (CC BY-SA 4.0)

All articles published by IBR are licensed under the Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0). Under this license:

  • Authors retain full copyright and grant the journal the right of first publication.
  • Readers are free to Share (copy and redistribute) and Adapt (remix, transform, and build upon) the material for any purpose.
  • Appropriate credit must be given, and if you remix or build upon the material, you must distribute your contributions under the same license as the original.

Ethical Compliance & Preservation

IBR strictly adheres to the ethical guidelines set forth by the Committee on Publication Ethics (COPE) and the Directory of Open Access Journals (DOAJ). Our Open Access policy is designed to comply with major funder mandates and international initiatives, including Plan S and the Budapest Open Access Initiative (BOAI).

To ensure the long-term availability of scholarly content, all articles are digitally preserved in the PKP Preservation Network (PKP PN) and the National Library of Indonesia, ensuring that research remains accessible to future generations of scientists.

Core Benefits of the IBR Open Access Model

01

Immediate Impact: Articles are available online instantly upon publication, ensuring maximum visibility.

02

Increased Citations: Open access papers typically receive higher citation counts due to unrestricted global access.

03

Author Rights: Authors maintain intellectual control over their work without transferring ownership to the publisher.

04

Global Equity: Researchers in developing nations can access high-quality biological data without financial barriers.

Publisher Information

PT. Inovasi Analisis Data

Semarang, Central Java, Indonesia

ISSN (E): In Process | ISSN (P): In Process

Contact Office

Email: ibr@analysisdata.co.id

Website: analysisdata.co.id/IBR

© 2025 Innovation Biology Research (IBR). This statement is licensed under CC BY-SA 4.0.